Low-dose-oral immunotherapy for children with wheat-induced anaphylaxis.
Ken-Ichi NagakuraNoriyuki YanagidaSakura SatoMakoto NishinoKyohei TakahashiTomoyuki AsaumiKiyotake OguraMotohiro EbisawaPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2020)
For patients with wheat anaphylaxis, low-dose OIT safely induces immunologic changes, achieves low-dose desensitization, and may allow for a 400 mg dose.